在炎症性呼吸道疾病中,氨酸的调节机制
Peidao Sun1, Xiangchen Chen2, Yuhang Wang2
1The Affiliated Hospital, Shandong University of Traditional Chinese Medicine, Jinan, China.
Frontiers in pharmacology
|December 15, 2025
概括
植物类黄胺 (Luteolin) 是一种植物类黄胺,通过减少炎症和氧化应激减轻炎症和氧化应激,显示出治疗喘和COPD等炎症性呼吸道疾病的前景. 需要进一步的研究来证实它在人类中的有效性和安全性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 呼吸系统疾病对全球健康构成重大挑战.
- 药用植物提供治疗药物,在炎症性肺部疾病方面,黄素越来越受到关注.
研究的目的:
- 审查在各种炎症性呼吸道疾病中黄素的药理学活性.
- 总结关于黄素的作用机制和治疗潜力的证据.
主要方法:
- 关于黄素和呼吸系统疾病的研究文献综述.
- 数据来源于PubMed,科学网,谷歌学者,CNKI和万芳数据库.
主要成果:
- 氨酸通过调节氧化应激,炎症和免疫反应来表现出多目标的保护作用.
- 它抑制了关键的信号通路 (NF-κB,MAPK,TLR4/NF-κB,NOX4/NF-κB) 和炎症酶激活.
- 氨酸通过调节巨细胞极化,T细胞分化和调节T细胞功能来恢复免疫平衡.
结论:
- 在炎症性呼吸道疾病的临床前研究中,氨酸表现出良好的安全性和肺部分布.
- 它具有作为治疗候选者的潜力,但需要进一步的临床验证.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Inflammatory Response
15.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K


